Publication | Open Access

A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705

Pretreated PatientsPhase Ii TrialMedicineErlotinib MonotherapyPathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerMolecular OncologyCancer Growth